While some say having lots of kids can make you lose your faculties, a new study suggests otherwise. Research co-led by UT Health San Antonio, the academic health center of The University of Texas at San Antonio, associates ...
7 minutes ago
0
0
You're in the kitchen, baking a cake, and the recipe calls for two cups of sugar. By the time you choose between the brown and white sugar, you've forgotten how much you need, and you have to check the recipe again. That's ...
7 minutes ago
0
0
Researchers from the Keck School of Medicine of USC have made an important advance toward understanding—and potentially treating—a rare cardiomyopathy (heart muscle disease) that is present from birth. The condition, known ...
27 minutes ago
0
0
A Brazilian study based on postmortem toxicological analyses found that 53% of violent death victims had alcohol or drugs in their systems shortly after death. The study examined 3,577 cases in Belém (North), Recife (Northeast), ...
27 minutes ago
0
0
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC), according to a ...
47 minutes ago
0
0
Recent studies suggest that animals and people alike have close and complex relationships with the bacteria around and within them. The human gut microbiome, for instance, has been associated with both depression and Parkinson's ...
47 minutes ago
0
0
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American ...
1 hour ago
0
0
New research reveals that as people age, naps may be an easily trackable warning sign of underlying conditions or declining health. A new study by investigators from Mass General Brigham and Rush University Medical Center ...
1 hour ago
0
1
The need for medical treatments for rare diseases such as Leigh syndrome is high. However, low patient numbers make research into treatments difficult. Together with a team from the University of Luxembourg, researchers from ...
1 hour ago
0
0
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D ...
1 hour ago
0
0
